Oct. 24, 2012
/PRNewswire/ -- Philips Respironics, a unit of
Royal Philips Electronics (NYSE: PHG, AEX: PHI), announces that the United States Federal Aviation Administration (FAA) has approved the SimplyGo portable oxygen concentrator (POC) for in-flight use on commercial airliners.
With the approval, SimplyGo becomes the only FAA-cleared POC that offers both continuous flow and pulse-dose capabilities in a unit weighing ten pounds or less. SimplyGo has twice the oxygen output of any other POC at this weight and is able to meet the portable needs of nearly all oxygen users. FAA approval applies to all SimplyGo systems including those in use prior to the announcement.
The FAA rule approving the use of SimplyGo for in-flight use on U.S. carriers will become effective on or about
October 31, 2012
, which is 15 days after publication of the new rule in the Federal Register.
To view the FAA statement, go to
"We are extremely pleased to inform oxygen users that they will be able to fly with the SimplyGo POC," said
, senior director and general manager, Home Respiratory Care, Philips Respironics. "Given its portability, oxygen output and continuous flow capability, we believe that SimplyGo is an ideal choice for oxygen users who are active or like to travel."
The Department of Transportation requires that U.S. carriers allow passengers to use portable oxygen concentrators approved by the FAA during all phases of a flight – including taxiing, takeoff and landing – if the unit meets FAA requirements for portable medical electronic devices, is properly stowed and meets certain other applicable safety-related conditions.
Special Federal Aviation Regulation 106 – Rules for use of portable oxygen concentrator systems on board aircraft (SFAR 106)
SFAR 106 permits passengers to carry on and use certain POCs on board aircraft if the aircraft operator ensures that the conditions specified in the SFAR for their use are met.